Brief: Synact Pharma Q4 Operating Expenses Up At SEK 91.1 Mln
23/02/2024 06:44
Feb 23 (Reuters) - SynAct Pharma AB SYNACT.ST :
* Q4 OPERATING EXPENSES AMOUNTED TO SEK 91,062 (30,523)
THOUSAND
* Q4 GROUP’S LOSS AFTER TAX AMOUNTED TO SEK 90,543 (30,477)
THOUSAND
Source text for Eikon: ID:nMFN3nfz2p
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026